Ortho-McNeil's Re-Entry into the Diabetes Arena
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)
Published: 1 Feb-2005
DOI: 10.3833/pdr.v2005.i56.721 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Arena's US$608 M GPCR collaboration agreement with Ortho-McNeil is one of the highest value preclinical deals in biotech's history...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS